Raffaele Petrone

Raffaele Petrone is the founder of PHD Pharmaceuticals Ltd. (2003), Fin Posillipo SpA (1989), Onkogen BV (2003), BCN Farma SA (2000), and Health Triage S.r.l.
(2020).
Mr. Petrone is the Chief Executive Officer of Fin Posillipo SpA. Mr. Petrone is the Chairman of BCN Farma SA and Health Triage S.r.l.
Mr. Petrone is the Chairman of Pierrel SpA since 2014, the Chairman of the European Association of Euro-Pharmaceutical Cos.
since 2008, and the Chairman of Petrone Group Srl.
Mr. Petrone is the Director of F.
Posillipo España SL since 2003, the Director of Prestifin SpA since 2007, the Technical Director of Euromed Srl since 1997, the Director of EuPharmed Srl since 2005, the Director of Quick-No Problem Parking SpA since 2007, the Director of Pierrel Research International AG since 2013, the Director of Si.Ge.A. Costruzioni Srl since 2007, the Director of STM Pharma Pro Srl since 2006, the Director of Logistica Farmaceutica Srl since 2006, and a Non-Executive Director of Newcleo Ltd. Mr. Petrone is a Partner of Pharmaidea Srl since 2001 and a Member of Ordine dei Farmacisti della Provincia di Napoli since 1987.
Former positions include Chairman & Chief Executive Officer of THERAMetrics holding AG (2013-2017), Chief Executive Officer & Director of ICU Medical Italia Srl (1997-2007), Vice Chairman & Chief Executive Officer of RELIEF THERAPEUTICS Holding SA (2013-2017), Chief Executive Officer & Director of Comercial Anonima Vicente Ferrer SA (2001-2020), Vice Chairman of Life Sciences Capital Srl (2009-2018), Director of Advanced Accelerator Applications SA (2006-2014), and Member-Supervisory Board of Cerma SA (2013).
Education includes an undergraduate degree from Università degli Studi di Napoli Federico II (1986).